A phase IIb study of Minerval (2OHOA) in patients with Glioblastoma multiforme

Trial Profile

A phase IIb study of Minerval (2OHOA) in patients with Glioblastoma multiforme

Planning
Phase of Trial: Phase II

Latest Information Update: 25 Nov 2015

At a glance

  • Drugs 2-hydroxyoleic acid (Primary)
  • Indications Glioblastoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 25 Nov 2015 New trial record
    • 23 Nov 2015 According to Lipopharma media release, company is opening a fund raising campaign to conduct this trial and if successful then it could could lead to a conditional approval in Europe for the treatment of newly-diagnosed GBM in combination with radiotherapy and temozolomide.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top